Login / Signup

Phase I investigator-initiated study of the safety of MTC001 in patients with chronic ischemic heart failure.

Takeshi MachinoAkira SatoNobuyuki MurakoshiMasaki Ieda
Published in: Medicine (2022)
This study was registered with the Japan Registry of Clinical Trials (jRCT2033210078).
Keyphrases
  • heart failure
  • clinical trial
  • randomized controlled trial
  • ischemia reperfusion injury
  • open label
  • subarachnoid hemorrhage
  • cerebral ischemia
  • double blind
  • phase iii
  • placebo controlled